Find verified Raltegravir API manufacturers, suppliers, and distributors across the globe. Explore companies that offer high-purity Raltegravir for pharmaceutical use, along with product details, certifications, and reliable sourcing options. Compare prices, check availability, and connect directly with trusted suppliers for Raltegravir API.
Alternate Names: Isentress(TM), hydropyrimidine-4-carboxamide, MK-0518, raltegravirum
CAS No: 518048-05-0
PubChem CID: 54671008
Mol Formula: C20H21FN6O5
Mol Weight: 444.4 g/mol
IUPAC Name: N-[2-[4-[(4-fluorophenyl)methylcarbamoyl]-5-hydroxy-1-methyl-6-oxopyrimidin-2-yl]propan-2-yl]-5-methyl-1,3,4-oxadiazole-2-carboxamide
API Description: Raltegravir is an antiretroviral drug produced by Merck & Co., used to treat HIV infection. It received approval by the U.S. Food and Drug Administration (FDA) on 12 October 2007, the first of a new class of HIV drugs, the integrase inhibitors, to receive such approval. Raltegravir is a Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor. The mechanism of action of raltegravir is as a HIV Integrase Inhibitor.
